ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT NOVEMBER 2024

News provided by

Dec 04, 2024, 03:19 ET

GOTHENBURG, Sweden, Dec. 4, 2024 /PRNewswire/ -- Zinzino group revenue increased with a total of 26 %, compared with the previous year.

The revenue in November for Zinzino's sales markets increased by 26 % and amounted to SEK 252.7 (201.1) million. Faun Pharma's external sales increased by 33 % and amounted to SEK 10.0 (7.5) million. Overall, the Group increased revenues by 26 % to SEK 262.7 (208.6) million compared with the previous year.

Accumulated revenue for January – November 2024 increased by 21 % to SEK 1955.9 (1611.0) million.

Revenues were distributed as follows:

Regions,MSEK	24-Nov	23-Nov	Change	YTD 2024	YTD 2023	Change
The Nordics	29.0	27.9	4 %	272.0	273.6	-1 %
Central Europe	70.9	49.9	42 %	519.2	394.5	32 %
East Europe	52.4	49.8	5 %	366.8	362.3	1 %
South & West Europe	45.1	35.5	27 %	346.7	242.0	43 %
The Baltics	16.2	13.0	25 %	95.7	89.8	7 %
North America	25.9	15.2	70 %	179.2	100.2	79 %
Asia-Pacific	10.8	8.3	30 %	64.2	51.3	25 %
Africa	2.4	1.5	60 %	15.0	12.3	22 %
Zinzino	252.7	201.1	26 %	1858.8	1526.0	22 %
Faun Pharma	10.0	7.5	33 %	97.1	85.0	14 %
Zinzino Group	262.7	208.6	26 %	1955.9	1611.0	21 %

Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa